325 Capital LLC Purchases 206,009 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

325 Capital LLC raised its holdings in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 30.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 886,916 shares of the company's stock after purchasing an additional 206,009 shares during the quarter. Astrana Health comprises approximately 10.8% of 325 Capital LLC's portfolio, making the stock its 4th largest holding. 325 Capital LLC owned about 1.58% of Astrana Health worth $27,964,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in ASTH. Pilgrim Partners Asia Pte Ltd purchased a new stake in Astrana Health during the 4th quarter valued at approximately $40,000. Quarry LP raised its stake in shares of Astrana Health by 35.5% during the fourth quarter. Quarry LP now owns 1,799 shares of the company's stock worth $57,000 after purchasing an additional 471 shares during the last quarter. KBC Group NV lifted its holdings in shares of Astrana Health by 108.4% during the fourth quarter. KBC Group NV now owns 2,530 shares of the company's stock worth $80,000 after purchasing an additional 1,316 shares during the period. US Bancorp DE raised its holdings in Astrana Health by 3,880.0% during the fourth quarter. US Bancorp DE now owns 4,776 shares of the company's stock worth $151,000 after purchasing an additional 4,656 shares in the last quarter. Finally, Pictet Asset Management Holding SA increased its holdings in shares of Astrana Health by 21.9% in the 4th quarter. Pictet Asset Management Holding SA now owns 7,075 shares of the company's stock valued at $223,000 after purchasing an additional 1,273 shares in the last quarter. 52.77% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ASTH has been the topic of several recent research reports. Robert W. Baird decreased their price objective on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Stifel Nicolaus decreased their price objective on Astrana Health from $70.00 to $56.00 and set a "buy" rating on the stock in a research note on Thursday, February 20th. Truist Financial decreased their price target on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a research note on Tuesday, March 18th. Barclays initiated coverage on Astrana Health in a report on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 price target for the company. Finally, Bank of America dropped their target price on Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a research note on Tuesday, March 4th. Three research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $53.29.

Astrana Health Trading Up 0.0 %

Shares of NASDAQ:ASTH traded up $0.02 during trading on Wednesday, reaching $32.06. 41,858 shares of the stock were exchanged, compared to its average volume of 278,684. Astrana Health, Inc. has a 12-month low of $23.12 and a 12-month high of $63.20. The firm's 50-day moving average price is $30.57 and its 200 day moving average price is $36.81. The firm has a market cap of $1.80 billion, a price-to-earnings ratio of 24.64, a price-to-earnings-growth ratio of 1.37 and a beta of 1.00. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $665.21 million during the quarter, compared to analyst estimates of $617.24 million. On average, sell-side analysts anticipate that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.